A comprehensive genetic investigation led by Dr. Feng Liu at Tianjin Medical University General Hospital has uncovered ...

Struggling with distressing menopause symptoms? So many of us are. In a 2023 survey, 81 percent of menopausal and ...

SMA children who can't walk have weaker upper leg bones than kids with cerebral palsy who are nonambulatory, a comparative ...

With a pair of Phase III trial flops, Ultragenyx will explore cost reductions as analysts turn attention to an upcoming ...

Figs, or anjeer, can have various health benefits. Here is how they can benefit long-term health and reduce certain risks for ...

Walking can bring health benefits, which can vary with different walking styles. See what happens when you enjoy brisk ...

A new study suggests that drinking tea regularly may protect bone health. Experts explain the link, and reveal whether you should drink more tea to support your bones.

In a 10-year study of postmenopausal women, tea consumption shows a small but significant benefit for bone mineral density, ...

Ultragenyx is developing setrusumab in pediatric and young adult patients across OI sub-types I, III and IV with two late-stage studies: the pivotal Phase 2/3 Orbit study and Phase 3 Cosmic study.

Neither study achieved its primary endpoint of reduction in annualized clinical fracture rate compared to placebo (Orbit) or bisphosphonates (Cosmic) Both studies achieved the secondary endpoint of im ...

Ultragenyx Pharmaceutical said on Monday late-stage studies showed its experimental drug for a type of genetic bone disease failed to reduce the number of fractures that occurred per year. Shares of ...